.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Citi
Novartis
Moodys
Cipla
Cerilliant
Fish and Richardson
AstraZeneca
Federal Trade Commission
US Department of Justice

Generated: September 23, 2017

DrugPatentWatch Database Preview

MITOMYCIN Drug Profile

« Back to Dashboard

What is the patent landscape for Mitomycin, and what generic Mitomycin alternatives are available?

Mitomycin is a drug marketed by Hospira, West-ward Pharms Int, and Accord Hlthcare. and is included in four NDAs.

The generic ingredient in MITOMYCIN is mitomycin. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mitomycin profile page.

Summary for Tradename: MITOMYCIN

Patents:0
Applicants:3
NDAs:4
Suppliers / Packagers: see list2
Bulk Api Vendors: see list52
Clinical Trials: see list178
Patent Applications: see list9,752
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MITOMYCIN at DailyMed

Pharmacology for Tradename: MITOMYCIN

Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064106-001Nov 29, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064180-001Dec 23, 1999APRXNoNo► Subscribe► Subscribe► Subscribe
Accord Hlthcare
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064144-001Apr 30, 1998APRXNoYes► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064180-002Dec 23, 1999APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064117-001Apr 19, 1995APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064117-002Apr 19, 1995APRXNoNo► Subscribe► Subscribe► Subscribe
Accord Hlthcare
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064144-003Aug 11, 2009APRXNoYes► Subscribe► Subscribe► Subscribe
Accord Hlthcare
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064144-002Apr 30, 1998APRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Argus Health
Julphar
Cerilliant
Queensland Health
Chubb
Covington
Healthtrust
QuintilesIMS
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot